rfhg_236924.1

Basic information about the TSS

---

TSS ID: rfhg_236924.1 Species: human Chr: chrX		Start: 71574298 End: 71574370 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF070560:-72 GeneID: 8473 HGNC/MGI_ID: HGNC:8127 UniProt_ID: Nearer transcript ids and distances: AL049950:-395

Gene_name: O-linked N-acetylglucosamine (GlcNAc) transferase Gene_symbol: OGT Gene_synonyms: FLJ23071 HRNT1 MGC22921 O-GLCNAC OGT1 Gene_source: HGNC:8127

TATA-Box annotation

---

Distance to TSS:	-3690
Nearest PromoterID:	NM_052957
Entrez ID:	93953
Nearest Unigene:	Hs.135167
Nearest Refseq:	NM_052957
Nearest Ensembl:	ENSG00000147174
Gene Name:	O-linked N-acetylglucosamine (GlcNAc) transferase
Gene Alias:	ACRC|NAAR1
Gene Type:	protein-coding
CpG%:	0.013889
GC%:	0.369863
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	22(CTTTTTATAGGT,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@OGT p2@OGT p3@OGT p4@OGT p5@OGT p8@OGT p10@OGT
Sample		p1@OGT	p2@OGT	p3@OGT	p4@OGT	p5@OGT	p8@OGT	p10@OGT
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	69.35	7.40	4.09	2.14	2.53	0.78	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	62.72	8.09	3.84	4.25	1.42	1.42	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	68.87	6.56	5.98	5.02	3.09	0.77	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	71.52	4.99	4.16	4.37	4.37	1.04	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	64.12	6.52	5.40	3.15	2.92	1.57	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	75.20	5.62	3.88	1.55	2.91	0.58	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	90.42	10.02	3.05	3.49	1.09	0.87	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	90.59	10.66	2.91	1.45	1.21	1.21	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.38	8.76	5.13	1.07	2.56	0.85	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	130.42	8.11	3.48	2.90	4.06	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	131.38	8.89	3.23	3.64	5.66	0.40	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	126.84	10.57	6.10	2.44	0.41	2.03	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	51.74	6.77	2.26	3.22	1.29	0.16	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	57.13	7.82	1.50	2.10	1.35	0.75	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	47.64	10.76	1.54	3.07	0.88	0.88	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	43.76	6.29	0.75	1.51	2.51	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	41.50	6.33	2.18	2.40	0.66	1.09	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.43	4.64	2.53	3.80	1.27	0.42	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	49.58	9.06	1.60	1.60	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	41.37	7.67	0.75	2.56	1.20	0.45	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	43.97	7.48	2.14	1.47	2.27	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	49.20	8.46	1.38	3.45	1.04	0.35	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	48.08	6.85	1.68	1.42	0.26	0.52	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	46.59	7.52	2.91	2.67	2.18	0.24	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	51.86	9.03	2.84	2.32	1.29	0.26	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	44.63	5.70	1.90	1.58	1.58	0.32	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	46.70	6.59	1.10	2.75	2.75	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	55.64	8.96	1.41	1.41	0.71	0.47	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.57	6.30	1.62	1.29	0.97	0.32	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	46.69	5.61	1.99	2.90	1.45	0.72	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.57	6.91	2.72	3.56	1.26	0.63	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.32	7.03	2.93	2.15	0.59	0.98	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.51	6.54	4.01	4.64	1.69	1.06	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	62.68	9.40	3.63	2.64	1.15	1.32	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	37.40	6.92	1.87	2.99	0.93	0.37	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.45	7.66	2.11	2.68	0.96	0.19	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	39.45	8.58	2.04	1.23	2.25	0.82	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	41.51	4.63	1.21	0.81	0.40	0.60	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.41	6.75	2.16	4.05	1.35	1.08	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.81	7.44	1.68	0.96	0.48	0.24	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	32.23	6.12	1.18	1.65	0.71	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.02	8.78	1.17	1.90	1.46	0.44	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	43.65	5.91	0.63	1.90	1.05	0.21	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	38.29	5.42	1.57	1.75	0.35	0.52	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	41.56	6.42	1.61	1.20	0.60	0.20	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	41.41	7.91	3.26	2.33	1.16	0.70	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	38.86	7.20	0.96	4.08	0.48	1.44	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.79	3.87	1.79	2.68	0.60	0.30	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.67	6.46	3.11	3.35	0.24	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	49.13	8.09	0.81	1.82	0.81	1.42	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	65.59	9.84	1.23	1.84	0.82	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	52.70	7.78	1.56	5.34	3.11	0.44	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	237.87	41.98	195.89	27.98	0.00	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	57.13	7.81	2.84	2.13	1.77	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	57.99	6.96	2.98	1.66	0.33	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	161.91	31.04	13.42	7.55	3.36	1.68	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	85.88	12.40	1.84	5.05	2.30	0.46	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	62.55	5.19	2.27	3.57	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	43.68	6.10	2.89	6.10	3.85	0.96	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	70.10	11.32	2.20	4.71	0.94	0.63	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.71	7.76	2.12	2.82	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	37.01	7.85	1.12	1.12	2.80	0.00	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	89.17	12.74	10.35	22.29	2.39	3.18	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	63.88	9.85	2.72	4.42	2.04	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	55.24	9.10	1.95	7.15	1.30	0.97	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.50	7.45	1.77	5.68	3.19	2.84	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	16.16	113.15	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	15.79	102.67	15.79	7.90	15.79	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	59.96	4.88	1.46	3.41	1.95	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	48.60	4.96	2.48	1.98	0.50	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	58.17	4.69	1.88	3.28	0.94	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	75.51	4.31	1.99	4.31	1.99	0.99	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	65.27	4.95	2.17	3.09	0.62	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	61.15	4.59	1.83	2.45	1.53	0.92	0.31
Adipocyte - breast, donor1	11376-118A8	46.25	8.24	4.28	0.95	0.95	0.00	0.95
Adipocyte - breast, donor2	11327-117E4	47.01	10.27	3.21	0.96	0.48	0.48	0.80
Adipocyte - omental, donor1	11473-119C6	68.83	13.10	2.16	1.27	0.51	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	23.92	4.48	3.74	0.00	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	31.15	5.69	1.34	0.67	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	28.71	3.83	3.83	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.06	0.00	0.00	0.45	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.99	3.48	0.35	0.17	0.00	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	64.34	11.73	0.78	0.78	0.59	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	49.93	4.38	2.32	0.77	1.03	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	50.18	6.41	3.35	1.39	0.56	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	61.13	7.64	3.53	1.76	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	54.37	12.23	2.57	0.32	0.32	0.24	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	45.51	4.84	3.23	1.29	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	45.32	7.46	2.13	0.00	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	39.51	8.35	2.78	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	34.52	7.07	0.42	0.83	0.00	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	36.92	9.80	1.26	0.25	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	39.60	6.54	2.95	0.33	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	28.92	3.96	1.52	0.91	1.22	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.06	1.55	0.00	0.22	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	38.14	5.76	1.08	0.18	0.00	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	21.57	2.67	0.62	0.21	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	21.17	5.49	1.26	0.34	0.11	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	13.47	4.65	1.96	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	30.10	4.49	1.35	0.00	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.88	5.21	0.00	0.43	0.00	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	0.00	4.28	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	23.91	7.77	1.49	0.30	1.20	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	34.15	5.06	3.79	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	28.38	3.96	1.32	1.98	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.34	4.87	2.27	0.65	0.00	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	6.31	1.94	0.49	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	0.00	1.19	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	32.77	7.91	2.26	0.75	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.22	7.98	1.45	0.00	0.00	3.63	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	6.27	1.25	1.25	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	24.88	4.78	1.32	0.00	0.00	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	5.46	4.09	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.64	2.71	1.81	0.30	0.30	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.08	4.82	1.61	0.54	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.59	4.72	1.51	0.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.93	5.35	0.80	0.00	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	32.19	4.88	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	20.07	5.31	1.33	0.50	0.33	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	2.40	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	27.96	5.32	1.20	0.34	0.51	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	29.13	7.28	2.43	0.00	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	27.70	4.93	3.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	30.28	3.63	1.21	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	33.06	3.42	3.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.16	5.77	1.71	0.21	0.43	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.10	3.36	2.06	1.03	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	28.15	5.16	0.94	0.00	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	17.04	4.18	1.29	0.64	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	4.99	2.14	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	3.51	1.75	0.00	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.39	5.72	2.41	0.00	0.00	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	5.94	1.19	1.19	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	34.58	4.58	1.53	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.58	6.37	2.04	0.76	0.00	0.76	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.05	5.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.62	6.47	1.29	0.43	0.86	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	25.40	4.87	1.48	0.85	0.21	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	21.75	3.19	2.32	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	29.29	4.72	2.83	1.89	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.22	3.05	1.36	0.34	0.00	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	2.11	0.00	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.16	3.65	1.29	0.43	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.07	3.01	1.20	0.60	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	25.51	5.10	1.46	0.00	0.73	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	24.60	3.68	1.38	0.00	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.58	2.80	1.78	0.25	0.51	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.93	4.13	2.68	0.21	0.21	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.76	3.67	2.45	0.00	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	33.94	7.17	2.39	0.00	0.48	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	25.28	3.77	3.33	0.00	0.44	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	6.10	1.53	0.00	1.53	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.80	4.98	1.66	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.04	6.09	2.12	0.26	0.26	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.71	2.91	1.82	1.09	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	27.39	7.00	1.47	0.12	0.00	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	20.88	4.62	0.51	0.00	0.17	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	21.60	2.94	0.42	0.21	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	50.20	8.71	3.83	0.00	0.70	0.00	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	52.58	7.77	4.37	0.49	0.81	0.32	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	62.65	8.50	2.24	0.45	1.49	0.45	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	209.99	40.71	2.52	0.80	0.23	0.11	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	175.27	38.84	2.88	1.13	0.38	0.63	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	186.06	38.58	2.50	0.91	0.80	0.11	0.34
Basophils, donor1	12241-129G9	50.74	10.72	0.78	1.05	0.00	0.26	0.00
Basophils, donor2	12242-129H1	186.17	36.08	2.89	1.44	0.00	0.00	0.36
Basophils, donor3	12243-129H2	54.09	13.23	2.65	0.15	0.29	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	11.64	2.59	0.43	0.00	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.18	0.00	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	15.18	1.25	1.25	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	22.80	1.84	0.46	0.00	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	29.15	2.52	1.26	0.36	0.54	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	139.23	26.69	5.05	1.13	1.96	0.62	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	156.05	38.20	9.32	3.26	2.10	1.16	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	118.96	28.14	7.35	0.32	1.92	0.64	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	299.92	113.76	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	67.06	16.34	2.25	1.13	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	111.73	13.55	2.60	1.48	0.56	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	101.86	20.20	3.29	2.20	3.95	0.88	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	77.84	13.30	6.23	1.13	0.57	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	97.80	17.06	7.96	1.52	0.76	1.52	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	75.94	17.42	3.29	0.00	1.31	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	84.99	14.89	2.46	1.16	0.72	0.00	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	83.88	9.05	1.81	0.30	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	104.23	13.50	3.79	2.61	1.18	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	82.02	8.70	2.34	1.00	0.50	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	108.47	11.32	4.97	3.31	0.83	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	151.98	13.14	4.46	0.74	0.74	0.99	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	87.72	9.20	2.55	1.17	0.98	0.98	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	111.10	9.61	2.14	1.25	0.71	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	141.02	12.19	3.70	1.52	0.65	0.44	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	113.79	10.77	6.56	1.64	1.40	0.23	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	175.31	8.98	6.34	3.17	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	194.14	23.30	8.87	1.11	2.22	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	74.52	11.01	3.12	1.19	0.59	0.45	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	92.79	8.98	1.60	1.20	0.60	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	107.64	10.41	3.75	2.08	0.83	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	113.93	11.21	5.49	0.46	1.14	1.14	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	155.85	12.44	1.81	1.13	0.68	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	161.49	9.60	6.55	4.36	2.18	1.75	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	57.83	7.53	1.61	1.08	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	73.97	12.04	2.27	0.87	1.22	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	72.80	12.62	1.68	2.52	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	105.08	9.92	3.67	0.92	0.73	0.92	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	136.33	13.74	3.87	3.87	1.76	1.76	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	176.37	16.67	2.19	1.32	4.39	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	101.14	8.54	6.28	2.62	2.62	1.05	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	107.41	10.41	5.20	1.12	1.86	1.86	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	152.18	12.29	3.02	1.51	0.43	0.22	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	101.55	9.42	4.09	4.09	0.82	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	162.03	15.07	2.32	2.09	1.62	0.70	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	175.85	11.37	3.71	2.32	2.55	0.70	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	79.99	10.03	1.74	0.00	0.87	0.44	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	73.23	10.86	1.39	0.46	0.00	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	53.94	6.28	3.03	0.22	0.00	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	141.55	28.96	2.02	0.47	0.47	0.47	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	99.37	18.51	3.67	0.52	0.70	0.35	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	238.80	34.56	2.45	0.45	0.67	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	68.64	9.19	3.83	0.51	0.77	0.00	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	100.12	10.98	6.15	0.44	0.22	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	65.90	6.53	4.84	1.05	0.21	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	134.13	38.61	8.13	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	185.09	42.71	9.49	2.71	0.00	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	175.02	33.14	8.28	3.11	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	141.26	29.32	14.93	3.20	1.60	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	184.94	36.45	9.65	3.22	3.75	0.54	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	202.16	32.29	12.63	1.40	0.00	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	175.70	36.08	7.84	0.00	2.35	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	146.33	23.73	7.91	5.27	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	286.84	41.10	9.04	3.29	6.58	6.58	0.82
CD19+ B Cells, donor2	11624-122B4	237.21	37.00	13.78	3.63	5.80	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	254.43	36.35	7.07	3.53	1.51	1.51	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	177.38	37.58	6.46	0.40	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	111.06	21.97	9.59	2.40	1.60	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	99.40	37.15	3.01	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	124.16	36.52	4.49	1.12	0.00	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	93.94	29.31	9.39	0.75	1.13	1.13	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	150.17	33.15	9.92	0.68	0.45	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	303.50	109.97	13.21	1.43	3.57	1.07	1.79
CD4+ T Cells, donor2	11306-117C1	290.26	53.28	23.88	4.90	4.90	4.29	4.29
CD4+ T Cells, donor3	11382-118B5	250.40	50.32	17.69	8.84	5.79	3.66	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	396.13	94.95	3.83	1.02	1.79	0.77	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	298.49	77.49	11.23	1.57	2.25	1.35	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	288.04	74.45	12.65	4.31	2.87	1.72	2.30
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	289.67	76.33	12.33	1.90	0.47	0.47	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	348.35	110.26	30.20	4.92	1.40	0.00	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	379.07	75.81	13.18	0.00	0.00	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	267.79	53.47	6.94	1.88	1.16	0.58	2.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	188.95	46.77	10.34	3.39	2.71	3.05	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	191.03	45.78	12.41	3.71	3.39	2.42	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	264.50	54.69	17.93	0.90	2.69	0.90	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	291.39	64.99	17.12	0.35	0.70	1.05	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	597.05	123.19	15.84	5.28	2.64	0.88	4.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	395.08	82.64	7.17	3.37	3.37	1.69	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	213.59	37.61	13.71	8.73	5.82	3.95	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	212.51	38.09	13.70	5.01	5.35	2.67	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	443.53	131.62	13.60	4.35	2.18	2.72	2.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	606.69	173.11	26.80	3.75	1.07	0.54	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	471.62	114.77	44.83	8.97	3.59	1.79	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	313.74	67.87	8.34	2.60	0.93	0.93	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	209.04	44.84	8.23	3.03	1.30	0.65	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	257.86	50.86	7.36	1.89	2.10	1.05	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	276.06	61.18	7.08	1.01	2.02	1.52	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	283.35	67.15	8.67	0.87	0.87	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	677.26	123.34	11.33	3.92	4.36	0.87	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	352.84	87.10	14.85	1.98	3.46	1.48	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	272.34	79.39	11.08	0.00	1.85	2.77	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	277.77	68.40	12.56	1.40	1.40	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	357.24	116.59	6.65	1.38	0.00	1.94	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	486.86	144.29	14.48	1.47	1.72	1.96	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	378.84	80.08	13.86	1.54	6.16	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	388.20	92.39	14.68	2.86	1.43	2.15	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	240.99	66.48	8.31	4.15	1.38	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	249.80	52.71	8.18	1.64	2.29	0.65	3.93
CD8+ T Cells, donor2	11307-117C2	239.15	34.92	20.65	5.63	4.13	2.63	2.63
CD8+ T Cells, donor3	11383-118B6	305.26	68.42	15.40	5.05	9.85	1.77	4.54
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	75.01	13.08	2.52	3.67	1.15	1.61	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	69.26	12.94	3.59	3.59	1.68	1.20	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	91.65	13.95	3.01	3.01	1.92	0.27	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	122.79	23.72	2.40	2.10	0.30	0.90	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	76.79	13.20	3.12	2.16	1.68	0.24	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	87.09	14.55	3.87	2.50	1.82	0.45	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	70.62	13.69	1.30	1.74	1.09	1.30	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	87.38	12.11	2.63	2.11	0.79	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	79.50	12.90	1.64	2.35	1.88	0.47	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	77.28	12.38	2.42	1.51	3.02	0.91	3.32
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	76.40	11.62	2.61	1.45	0.87	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	86.32	13.32	1.60	0.80	0.80	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	94.55	11.82	1.75	1.31	1.75	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	111.12	13.21	3.19	1.37	3.19	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	91.74	8.95	0.75	5.97	4.48	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	82.12	11.89	3.24	2.16	0.72	1.08	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	76.25	15.25	2.59	1.73	1.44	1.15	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	68.35	14.38	1.89	1.65	1.41	0.47	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	109.65	22.50	4.44	0.95	1.27	0.32	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	92.88	19.68	3.38	1.23	2.15	1.23	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	100.98	19.88	1.92	0.64	0.96	0.96	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	102.88	18.74	1.53	4.59	2.29	1.15	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	94.59	13.40	1.58	1.58	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	93.80	17.40	5.29	2.27	0.76	0.76	3.78
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	203.15	23.29	7.23	5.62	8.83	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	207.73	27.28	9.09	4.90	6.99	1.40	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	301.53	44.08	7.01	9.02	2.00	1.00	4.01
Cardiac Myocyte, donor1	11525-119I4	45.69	1.83	0.00	12.79	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	23.22	0.99	0.49	0.00	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	11.26	0.95	0.11	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	31.20	9.36	1.73	0.00	0.69	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	21.68	2.84	0.71	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	30.72	5.58	2.73	0.34	0.91	0.57	0.57
Chondrocyte - re diff, donor2	11339-117F7	56.40	11.64	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	36.40	6.07	0.00	0.81	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	69.31	14.57	3.67	0.69	0.46	0.69	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	56.43	9.19	3.85	0.86	0.43	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	52.21	8.32	1.77	0.53	1.06	0.27	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	107.47	31.91	1.38	0.37	0.46	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	5.27	0.66	0.22	0.00	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	7.96	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.46	1.28	0.51	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	52.67	9.41	2.15	0.66	0.99	0.83	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	46.68	9.46	3.47	0.95	0.63	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	24.15	3.45	3.45	0.00	3.45	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	45.68	7.88	1.84	0.97	0.54	0.22	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	442.43	106.93	33.48	6.15	5.47	3.07	3.07
Dendritic Cells - plasmacytoid, donor2	11309-117C4	430.89	79.00	11.75	0.65	1.96	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	609.29	140.83	16.94	1.45	0.97	1.45	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	25.68	5.34	0.67	0.33	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	1.17	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	29.41	2.83	1.13	0.57	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	18.09	3.93	0.00	0.39	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	23.56	2.33	0.29	0.00	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	23.29	3.53	0.47	0.24	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	23.14	5.26	0.53	0.00	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	47.88	14.41	2.22	0.89	0.66	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.47	11.87	2.13	0.30	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	59.48	14.10	0.28	0.28	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	20.80	6.24	0.89	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	19.26	0.52	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	21.41	3.83	0.57	0.28	0.28	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	36.41	6.00	3.20	0.40	0.40	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	16.77	3.14	2.10	0.52	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	90.45	12.18	3.73	0.25	0.25	0.50	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	42.80	3.04	1.74	0.65	0.00	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	31.75	4.64	0.85	0.61	0.24	0.49	0.12
Endothelial Cells - Vein, donor1	11267-116G7	18.20	2.28	0.00	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.05	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	24.34	3.30	2.04	0.31	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	76.23	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	95.72	34.66	0.00	0.00	1.65	1.65	0.00
Eosinophils, donor3	12246-129H5	57.07	17.83	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.86	1.22	0.24	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	68.97	11.90	3.69	1.64	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.02	0.66	0.22	0.33	0.22	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.04	1.52	0.11	0.22	0.11	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	55.55	8.73	0.73	0.61	0.61	0.00	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	276.63	82.57	5.46	1.50	1.36	0.41	2.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	41.55	8.65	0.95	0.42	0.63	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	301.43	46.37	5.27	2.63	0.79	2.37	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.15	12.96	0.33	1.00	1.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	27.67	4.54	1.36	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	22.74	3.79	0.76	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	16.56	3.31	0.47	0.16	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	65.17	11.82	0.91	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	65.10	7.87	2.03	0.00	0.25	0.51	0.13
Fibroblast - Cardiac, donor6	11460-119B2	36.69	6.67	1.06	0.30	0.15	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	63.78	11.52	1.61	0.13	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.97	3.45	0.00	2.59	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	23.44	2.93	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	29.06	3.92	0.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	64.62	11.70	1.36	0.17	0.00	0.00	0.68
Fibroblast - Dermal, donor1	11269-116G9	27.23	5.87	0.23	0.23	0.23	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	22.64	4.25	0.47	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	25.87	5.68	1.81	0.73	0.24	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	54.83	6.78	1.36	0.11	0.11	0.34	0.11
Fibroblast - Dermal, donor5	11454-119A5	46.75	9.77	1.22	0.17	0.17	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	42.88	8.77	0.97	0.16	0.16	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	59.14	13.74	2.29	0.42	0.00	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	79.12	14.15	1.05	0.52	0.00	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	48.63	8.96	3.29	0.53	0.66	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	84.02	11.89	0.97	0.68	0.29	0.19	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	11.43	1.04	0.00	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.95	3.52	1.59	0.53	0.53	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.38	7.48	1.87	0.78	0.00	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.76	6.09	0.41	0.41	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	25.05	4.59	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	39.19	4.68	1.02	1.32	0.29	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	53.31	6.82	1.77	1.23	0.00	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	31.26	5.48	1.10	0.33	0.22	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	83.20	12.18	2.64	1.17	0.29	0.73	0.44
Fibroblast - Lung, donor1	11270-116H1	9.52	2.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	49.24	11.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.67	4.64	1.69	0.00	0.00	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	19.99	3.33	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.16	1.68	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	34.91	5.68	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	31.95	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	47.72	8.73	2.52	0.19	0.39	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	73.11	11.53	1.06	0.61	0.30	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.87	13.16	0.61	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	4.20	0.76	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	47.52	5.67	1.62	0.81	0.54	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.21	2.44	0.58	0.81	0.35	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.15	1.77	0.44	0.00	0.22	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.90	4.06	0.20	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	3.34	2.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	29.65	4.74	1.19	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	180.39	30.16	5.56	2.18	0.40	1.79	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	69.63	10.48	2.84	0.89	0.89	0.36	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	68.59	12.42	4.14	0.99	0.39	0.39	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	125.16	23.47	2.71	0.90	0.90	1.20	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	93.59	16.95	1.94	0.43	0.22	0.43	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	268.01	50.87	8.60	1.52	1.52	1.27	1.77
Fibroblast - skin normal, donor1	11553-120C5	56.94	13.95	1.80	0.33	0.82	0.16	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	163.41	43.31	5.41	2.01	0.80	0.80	0.80
Fibroblast - skin normal, donor2	11561-120D4	61.38	13.36	2.51	0.00	0.00	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	232.42	42.92	4.84	3.02	0.60	1.51	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	91.05	15.82	3.31	1.24	0.58	0.25	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	137.62	23.59	3.08	0.17	0.00	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	137.28	31.53	1.31	1.97	0.33	0.66	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	50.38	10.23	1.70	0.32	0.11	0.21	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	32.89	6.07	1.52	0.17	0.34	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.84	2.20	0.78	0.78	0.16	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	70.59	16.56	2.61	1.74	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	26.18	4.85	0.69	0.00	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	33.31	3.64	1.30	0.52	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	28.87	6.13	1.02	0.00	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	34.45	0.00	5.36	3.06	0.77	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	56.15	3.19	8.93	0.00	1.28	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	113.25	8.84	9.70	4.28	5.13	2.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	108.92	17.37	11.03	8.00	9.10	1.65	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	95.90	18.27	8.22	3.42	4.57	2.51	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	95.70	7.33	9.71	4.36	4.16	2.18	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	106.26	12.69	9.52	3.70	4.49	3.17	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	106.98	18.59	4.89	2.94	5.22	1.63	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	86.23	7.52	11.94	6.63	7.52	1.77	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	73.91	10.74	3.67	0.57	0.85	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	62.68	7.14	2.46	1.48	1.11	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.14	4.84	2.69	0.54	0.27	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.55	6.94	1.49	0.99	0.50	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	50.25	6.51	2.91	0.55	0.55	0.28	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	58.55	7.52	2.64	0.41	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.50	6.62	1.60	0.68	0.46	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	54.81	7.60	2.24	0.37	0.62	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	48.52	4.59	2.40	1.09	1.31	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.35	5.61	2.95	0.30	0.30	1.18	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	69.62	10.49	2.54	0.48	1.11	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.33	4.69	1.79	0.45	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	67.95	7.86	1.21	1.01	1.01	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	68.20	6.62	3.56	0.85	0.51	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	65.53	8.69	2.04	0.62	0.35	0.27	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	90.63	11.34	1.77	0.42	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	86.58	9.91	1.54	0.34	0.34	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	59.53	7.52	0.89	0.77	0.55	0.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.23	6.99	2.41	0.50	0.42	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	57.37	6.74	1.84	0.41	0.41	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	62.30	7.63	5.16	0.21	0.41	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	58.57	7.15	3.34	1.38	1.61	0.46	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.37	7.84	2.17	1.00	1.00	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	50.92	3.97	2.65	0.44	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	71.83	8.73	3.69	1.35	0.86	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	58.84	7.62	2.11	0.32	0.49	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	69.27	9.94	1.92	0.32	0.96	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	49.18	5.21	1.99	0.66	0.19	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.02	4.27	1.90	0.47	0.00	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	69.33	4.56	2.13	0.91	0.61	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	50.28	6.17	4.81	1.25	0.73	0.63	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	50.94	5.93	1.98	0.66	0.88	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	49.38	5.89	3.09	1.12	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	42.59	5.93	1.20	0.93	0.46	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	38.77	2.94	1.87	0.80	1.60	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.11	3.52	1.68	0.61	0.15	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	34.72	3.63	1.30	0.13	0.26	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	40.39	3.80	2.98	0.27	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	57.15	7.37	2.40	0.74	0.37	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	52.64	5.70	1.75	0.66	0.66	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	79.34	8.93	0.99	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	53.16	4.49	3.17	0.26	0.66	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.61	6.05	1.82	1.41	0.20	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	88.96	12.45	0.25	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	79.62	10.35	3.78	0.00	0.20	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	85.97	8.63	4.47	0.92	0.62	0.62	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	103.11	10.84	3.27	1.43	1.02	0.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	49.44	4.07	2.82	0.63	0.63	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.99	1.41	3.39	0.28	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	104.69	11.99	8.30	3.69	2.77	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	12.37	4.95	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	65.37	6.58	3.87	2.71	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	80.22	6.42	3.21	1.60	4.81	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	85.20	8.69	3.48	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	60.21	4.23	4.56	0.98	1.95	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	88.54	14.41	4.53	1.65	0.41	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	83.31	23.33	10.00	3.33	6.66	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	68.23	6.99	6.15	1.40	1.68	1.40	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	74.85	4.25	4.90	1.31	0.65	0.00	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	91.43	2.52	13.42	5.03	4.19	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	91.92	6.68	6.36	1.91	1.91	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	64.54	3.74	4.08	0.68	1.70	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	8.35	10.44	0.00	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.29	4.01	5.15	0.57	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	50.32	3.55	5.92	0.89	0.89	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	3.39	3.39	1.69	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	80.77	9.53	5.38	0.83	1.66	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.26	7.59	3.68	1.38	1.15	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	10.54	5.27	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	69.58	7.30	3.46	2.31	1.92	1.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	73.02	6.52	4.56	0.65	1.30	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	50.16	4.01	4.68	1.34	0.00	0.67	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	99.78	4.62	4.24	1.54	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	90.38	13.35	3.42	2.40	1.37	1.03	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	12.42	19.88	9.94	7.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	85.88	8.49	5.66	1.89	1.89	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.78	7.85	6.03	1.21	0.60	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	86.98	9.16	4.07	1.02	2.54	1.53	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	114.47	9.17	7.98	2.79	1.20	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	107.55	8.88	7.89	1.97	2.47	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	181.79	12.98	7.08	2.36	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	73.51	2.33	11.09	1.75	2.92	0.58	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	76.80	7.02	5.27	1.76	0.88	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	68.66	1.70	8.48	4.24	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	69.84	5.37	13.13	4.78	1.79	2.98	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	53.86	5.34	2.91	0.49	0.97	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	7.99	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	23.70	3.74	0.00	0.00	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	26.99	4.50	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.04	8.25	0.95	0.63	0.95	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.20	3.34	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	44.56	9.98	2.44	0.58	0.46	0.46	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	47.43	6.75	2.70	0.34	0.84	0.68	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	36.86	10.01	2.28	0.68	0.46	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	44.16	9.62	1.97	0.55	0.66	0.33	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	45.78	10.75	2.15	0.21	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	43.06	8.83	1.94	0.00	0.43	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	34.50	6.60	2.49	0.62	0.37	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	41.86	8.41	1.89	0.17	0.51	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	32.36	8.33	1.92	0.64	0.32	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.71	1.12	0.56	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	11.25	0.87	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	14.46	1.76	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	2.91	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.39	2.27	1.05	0.35	1.40	0.52	0.00
Hepatocyte, donor1	11523-119I2	52.06	9.68	3.63	1.21	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	66.79	7.54	2.15	1.08	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	74.24	11.66	3.68	1.84	1.23	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	248.02	31.98	15.01	9.14	3.26	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	94.91	9.09	4.19	0.35	0.35	0.17	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.27	5.49	0.55	0.14	0.00	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	73.23	15.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	48.45	11.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	15.02	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	56.38	10.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	74.72	22.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	35.01	8.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	68.98	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	48.97	11.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	42.13	5.54	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	26.19	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	49.13	10.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	43.31	9.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	55.56	14.86	1.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	56.35	16.10	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.08	13.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	45.34	16.79	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	67.51	12.86	0.00	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	40.62	6.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	35.87	8.97	0.47	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	36.28	7.26	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	63.49	12.91	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	52.09	7.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	62.49	15.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	71.08	12.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	18.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	56.41	23.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	62.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	38.58	10.19	0.93	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	63.22	8.78	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	78.58	12.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	56.33	13.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	53.11	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	6.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	44.47	7.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	45.00	13.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	10.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	49.07	16.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	12.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	11.40	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	42.34	15.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	24.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	56.04	15.86	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	21.54	2.53	0.41	0.00	0.08	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	8.20	1.76	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.30	2.75	1.14	0.09	0.19	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	45.07	3.86	1.70	0.23	0.23	0.23	0.34
Keratocytes, donor1	11527-119I6	15.82	3.09	0.00	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	15.23	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	34.38	3.36	2.37	0.59	0.59	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	48.35	19.78	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	31.28	5.39	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	32.18	6.34	1.15	0.23	0.00	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	23.61	5.55	0.10	0.10	0.30	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.24	3.68	0.47	0.24	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.60	0.84	1.67	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.66	5.67	3.15	0.47	0.31	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.22	2.15	0.00	1.08	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	1.58	1.26	0.00	0.63	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.39	2.16	1.94	0.11	0.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.77	0.41	2.05	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.34	1.26	1.26	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.47	2.53	1.55	0.14	0.14	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.17	1.58	0.79	0.79	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.18	2.52	1.55	0.00	0.39	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.96	1.48	0.74	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.86	1.74	1.05	0.00	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.45	1.91	1.91	0.48	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.09	1.37	0.82	0.55	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.09	2.77	1.85	0.92	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.73	1.87	0.31	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.21	2.01	0.91	0.18	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.46	2.30	0.99	0.66	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.96	0.88	0.88	0.00	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.71	2.24	1.00	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.82	4.36	0.48	0.48	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.04	1.35	1.08	0.27	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.80	2.88	1.82	0.00	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.14	4.15	1.56	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.96	1.47	0.84	0.21	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.53	2.41	1.20	0.30	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	4.82	3.44	0.00	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.48	3.20	0.38	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.51	2.33	1.80	0.11	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.93	2.42	1.94	0.00	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	2.98	0.00	0.00	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.99	2.73	1.73	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	36.28	7.40	1.48	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.88	2.47	1.73	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	12.24	1.10	1.65	0.00	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.80	4.82	1.93	0.64	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.39	4.87	2.13	0.00	0.61	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.33	4.48	2.80	0.00	0.28	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	2.49	0.71	0.00	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.70	0.00	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.54	2.33	0.31	0.16	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.47	3.22	0.36	0.36	1.07	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.78	2.94	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.24	1.88	0.94	0.00	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.78	3.84	0.62	0.12	0.25	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.17	1.02	1.28	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	2.69	0.90	0.30	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	30.69	5.37	0.00	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	3.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	47.39	6.77	0.42	0.85	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.17	11.25	2.11	0.00	0.00	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	32.69	3.74	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	34.01	8.76	0.52	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	27.36	2.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.08	8.60	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	42.75	8.72	2.91	1.74	0.58	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	42.77	9.00	1.80	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	45.66	8.81	0.41	0.14	0.00	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.14	5.14	3.59	0.51	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.17	6.70	2.47	0.35	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.98	7.33	1.33	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	42.79	10.70	3.57	0.00	1.02	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.42	10.67	1.60	0.27	0.53	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	51.20	8.69	4.53	0.57	0.57	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	37.43	7.98	1.23	0.00	0.00	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.03	7.34	1.63	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	50.60	7.29	3.54	1.25	0.83	1.04	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.80	5.61	3.64	1.96	1.12	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	43.27	5.15	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.58	6.97	4.06	1.45	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	43.94	3.89	4.78	0.90	0.30	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	30.98	7.19	4.43	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.89	8.84	1.41	0.71	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.41	8.48	1.84	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	3.45	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.08	8.44	0.38	0.38	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	42.46	9.62	1.70	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	34.46	6.56	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	36.60	7.68	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.85	16.52	2.15	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	28.38	4.48	1.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	40.88	4.09	1.86	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.71	6.89	1.72	0.43	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	28.26	5.14	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.65	8.33	3.00	1.00	0.00	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	29.56	5.43	1.81	0.60	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	2.84	1.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.53	5.84	0.69	0.00	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	38.65	4.29	4.29	0.00	0.00	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	33.67	2.69	0.00	0.00	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.12	8.15	1.48	0.74	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	2.33	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	26.44	3.17	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.81	5.60	2.00	0.80	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	44.34	6.54	1.45	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	41.39	6.90	0.77	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	53.27	7.40	0.99	0.00	0.49	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	40.46	8.47	0.94	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	40.23	8.05	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	43.71	4.96	0.45	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	37.86	6.88	0.00	0.00	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	46.32	4.90	0.89	0.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	43.40	7.82	1.96	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	50.14	8.58	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	37.36	8.30	0.52	0.52	1.56	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	50.76	6.56	1.31	0.88	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	46.41	6.15	1.12	0.56	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	52.11	7.95	1.32	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.99	8.10	2.70	0.39	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	45.57	6.58	1.52	1.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	38.45	6.25	1.44	0.48	0.96	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	48.10	11.13	1.19	1.19	0.00	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.61	8.51	1.22	0.00	0.00	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	40.81	11.07	2.08	0.00	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.06	9.12	1.14	1.14	0.38	0.38	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	8.26	2.58	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	39.30	4.84	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	48.49	7.29	1.27	0.32	0.00	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	41.05	8.53	0.00	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	37.35	10.92	1.72	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	51.42	8.74	1.03	0.51	1.03	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	51.64	6.37	3.54	0.71	0.71	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	35.18	4.54	1.70	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	36.61	4.16	0.42	1.66	0.00	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	42.28	8.61	0.78	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	43.42	6.68	0.42	0.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	36.24	5.58	0.93	0.46	0.46	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.12	8.70	0.00	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	35.29	8.55	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.58	6.06	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	36.71	2.75	0.92	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	37.34	12.45	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	38.75	6.27	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	8.44	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.28	4.38	2.74	1.09	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	34.30	6.68	0.00	0.00	0.45	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.95	6.24	0.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	32.49	7.96	0.66	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	51.97	6.24	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	39.66	7.52	4.33	0.23	0.23	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	27.16	6.42	3.12	0.18	0.00	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	33.43	4.46	1.18	0.66	0.13	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.21	1.59	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	50.23	5.70	0.79	0.00	0.32	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	41.70	5.14	0.56	0.00	0.56	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	29.00	6.28	1.20	0.00	0.50	0.10	0.30
Mammary Epithelial Cell, donor2	11350-117G9	30.69	5.79	1.74	1.16	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	17.21	1.50	0.25	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	2013.47	153.21	3.39	0.68	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	64.99	23.14	2.27	0.65	0.54	0.32	0.22
Mast cell, donor2	11565-120D8	83.21	23.48	0.59	1.19	0.59	0.30	0.30
Mast cell, donor3	11566-120D9	92.30	33.09	5.63	2.48	0.68	0.90	0.00
Mast cell, donor4	11567-120E1	74.99	25.00	2.48	1.06	0.35	0.53	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	269.91	51.79	3.44	1.44	0.78	0.67	1.33
Mast cell, expanded and stimulated, donor8	11942-126A7	269.66	27.43	6.42	1.75	1.17	1.75	1.75
Mast cell, expanded, donor5	11939-126A4	121.72	33.50	4.24	0.57	0.34	0.34	1.03
Mast cell, expanded, donor8	11941-126A6	142.93	27.95	4.18	1.17	0.50	0.67	0.00
Melanocyte - dark, donor1	11502-119F8	20.80	3.88	1.19	0.10	0.20	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	25.96	3.81	1.38	0.00	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	35.13	4.20	1.30	0.14	0.14	0.14	0.14
Melanocyte - light, donor1	11274-116H5	22.10	1.88	0.71	0.24	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	25.93	2.05	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.01	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.76	3.33	2.08	0.62	0.73	0.00	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	32.81	3.50	3.77	0.27	0.00	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	63.21	5.89	2.41	1.07	1.61	0.00	0.27
Meningeal Cells, donor1	11493-119E8	43.05	11.29	0.25	0.12	0.00	0.12	0.25
Meningeal Cells, donor2	11573-120E7	50.18	9.24	0.88	0.44	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	33.66	4.40	0.73	0.08	0.16	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.67	5.13	2.28	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	55.35	11.67	2.31	0.70	0.30	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	2.15	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	45.11	8.05	1.06	0.21	0.64	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.65	3.52	2.01	0.00	2.51	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.75	2.42	0.44	0.00	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	14.61	1.46	0.00	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.87	2.46	0.41	0.20	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.13	7.34	1.52	0.14	0.14	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.06	1.12	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.97	5.39	1.97	0.00	0.13	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	3.56	0.00	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.66	3.54	0.71	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.71	2.50	0.31	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.06	2.18	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	30.76	9.55	2.39	0.53	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	11.01	4.50	1.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	24.64	4.91	0.58	0.43	0.51	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	1.35	0.00	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	33.74	6.90	3.45	0.99	0.49	1.97	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	33.27	6.18	2.36	2.06	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.66	4.34	4.65	0.62	0.93	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.85	6.85	1.87	0.41	0.21	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	27.78	4.50	1.75	1.00	1.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.62	5.12	0.00	1.86	1.40	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.34	3.25	2.24	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.59	7.92	1.98	1.19	0.40	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	4.42	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.84	4.56	1.90	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.71	3.40	1.06	0.85	0.42	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	1.84	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.39	2.98	1.79	0.00	0.30	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	20.32	1.51	2.51	0.50	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.78	5.70	2.38	0.71	0.95	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	0.55	1.11	0.55	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.72	5.30	0.69	0.00	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.56	5.89	1.26	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	24.66	3.06	0.41	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.89	2.36	2.15	0.86	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.23	2.67	0.89	0.22	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.27	1.97	1.10	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	2.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.76	2.72	0.82	1.09	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.94	2.06	0.29	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.42	3.84	1.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.61	2.00	1.20	1.20	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	1.37	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	2.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.58	2.63	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	1.10	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	1.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	2.48	0.50	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.99	2.05	0.68	0.34	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	0.88	0.88	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	0.71	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	20.76	3.65	1.68	0.28	1.68	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.88	1.66	0.00	0.00	0.83	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.48	2.11	1.21	0.90	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	13.36	1.67	0.42	0.83	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	0.92	3.69	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.78	0.57	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.01	1.66	0.28	0.28	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.99	2.07	2.07	0.52	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.72	3.00	0.00	0.43	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.91	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.68	2.14	0.27	1.33	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.53	6.29	0.90	0.30	0.00	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.59	1.55	0.42	0.71	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.01	3.50	1.27	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.46	3.32	1.33	0.44	0.00	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.96	2.28	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.44	2.27	2.27	0.57	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.16	3.93	1.72	0.49	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	2.61	1.30	0.65	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.70	5.00	2.06	0.88	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.93	4.04	0.29	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.67	2.89	1.65	0.41	0.00	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.78	1.49	1.79	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	7.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.34	3.94	1.31	0.00	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	0.00	4.21	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.60	5.34	3.76	0.59	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	5.59	1.86	0.93	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	36.05	8.64	4.13	1.50	1.50	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.51	4.00	2.13	0.27	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.00	3.05	0.45	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	12.52	0.74	2.21	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	22.35	3.30	1.83	1.10	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	0.00	6.22	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.74	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	1.01	1.01	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.49	2.11	0.42	0.42	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	1.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	3.02	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	60.32	10.34	3.45	0.22	0.22	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	86.75	4.18	3.66	1.05	1.05	0.00	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	2.00	0.00	0.00	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	2.92	0.00	1.25	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	35.75	4.75	0.76	0.76	0.00	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	7.98	1.60	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	3.40	1.36	0.68	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	42.27	3.68	9.19	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.93	1.67	0.42	0.42	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.78	3.49	0.70	0.46	0.46	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.83	4.32	0.54	0.54	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.22	9.46	0.21	0.84	0.84	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	3.97	0.99	0.50	0.99	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	31.40	4.33	0.81	2.44	0.54	1.35	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.04	4.31	1.13	0.91	0.23	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.70	3.43	0.98	0.98	0.16	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.22	5.65	1.09	0.18	0.55	1.09	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.28	6.90	1.06	2.65	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.21	3.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	50.21	8.86	2.30	3.28	0.66	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	15.45	3.58	0.49	1.14	0.33	0.65	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	35.98	8.11	1.76	1.06	0.53	1.23	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	4.22	0.70	0.00	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.77	5.98	0.46	2.30	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.39	5.78	0.00	0.32	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	54.84	8.28	1.03	3.10	1.38	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	25.28	5.06	5.06	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.41	6.02	2.23	1.34	0.45	2.01	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.51	2.96	1.69	1.69	1.27	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	26.35	4.27	2.14	2.37	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	34.77	8.58	0.86	1.72	0.43	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	18.06	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.66	3.67	1.33	2.33	0.67	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.99	3.16	1.80	1.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.40	4.76	0.40	1.98	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	5.57	1.86	0.93	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	43.89	7.19	0.76	1.51	0.00	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.70	5.54	1.30	1.63	1.30	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	3.05	1.31	3.49	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.30	1.81	1.36	0.90	0.90	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	23.81	2.65	0.00	3.53	2.65	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.94	8.64	3.32	0.66	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	31.25	9.42	0.99	0.99	0.99	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	6.89	0.00	2.68	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.77	12.70	3.63	1.21	1.51	1.21	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	45.09	7.07	1.99	1.11	0.44	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.21	6.10	2.03	3.39	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	10.22	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	37.19	5.49	1.22	0.00	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.14	5.04	1.57	0.63	0.63	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.03	3.03	1.51	3.33	0.91	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	27.69	4.75	0.79	0.79	0.00	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	53.28	6.80	7.94	5.67	2.27	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	0.00	5.06	15.17	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	43.73	7.58	1.12	0.37	0.25	0.12	0.37
Myoblast, donor2	11322-117D8	53.32	9.97	0.58	1.15	0.38	0.19	0.38
Myoblast, donor3	11398-118D3	31.28	8.24	1.35	0.17	0.17	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	204.31	19.41	6.28	4.38	4.52	2.04	1.31
Natural Killer Cells, donor1	11230-116C6	244.48	49.20	10.15	2.15	1.85	0.31	3.08
Natural Killer Cells, donor2	11311-117C6	226.47	37.09	18.09	1.81	3.62	3.02	0.90
Natural Killer Cells, donor3	11387-118C1	236.33	45.83	12.15	2.94	6.44	1.47	2.39
Neural stem cells, donor1	11275-116H6	118.32	12.34	0.36	0.00	0.00	0.00	0.36
Neural stem cells, donor2	11352-117H2	140.57	32.74	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	68.27	18.21	4.55	0.00	0.00	1.14	1.14
Neurons, donor2	11574-120E8	74.86	16.29	5.50	0.66	0.44	0.00	0.22
Neurons, donor3	11655-122E8	77.28	18.09	4.11	0.82	1.64	0.82	0.00
Neutrophils, donor1	11233-116C9	95.58	20.42	0.93	0.00	0.00	0.00	2.78
Neutrophils, donor2	11314-117C9	113.06	5.80	0.00	2.90	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	141.72	36.04	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	35.03	6.17	0.83	0.36	0.24	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	20.19	2.28	0.65	0.33	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	19.05	5.41	1.40	0.00	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	87.68	12.94	3.99	1.65	1.10	0.83	0.28
Olfactory epithelial cells, donor2	11934-125I8	100.60	11.43	2.03	1.74	0.87	0.29	1.59
Olfactory epithelial cells, donor3	11935-125I9	91.71	12.60	3.86	2.04	1.02	1.36	0.45
Olfactory epithelial cells, donor4	11936-126A1	66.13	8.28	2.24	1.85	1.46	0.49	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	30.09	2.41	0.00	0.00	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	22.55	3.40	0.00	0.21	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	13.72	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	1.86	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	16.22	3.71	0.78	0.20	0.00	0.39	0.00
Osteoblast, donor2	11354-117H4	31.60	6.32	2.11	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	25.77	3.20	0.36	0.18	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	58.80	10.87	1.94	0.17	0.59	0.25	0.42
Pericytes, donor1	11491-119E6	7.45	2.23	0.22	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	9.05	3.40	0.00	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	22.99	4.68	0.61	0.00	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	49.73	8.93	1.47	0.34	0.57	0.00	0.34
Perineurial Cells, donor2	11579-120F4	28.34	4.42	0.64	0.09	0.18	0.00	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	284.00	95.94	12.43	1.91	1.27	0.96	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	198.83	36.73	9.55	1.96	4.41	1.22	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	211.21	37.92	4.40	1.81	0.78	0.65	1.94
Placental Epithelial Cells, donor1	11278-116H9	7.89	1.91	0.72	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	14.42	4.44	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.98	1.77	0.20	0.00	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.81	0.32	0.32	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	47.83	9.75	2.81	0.75	0.00	0.38	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	193.96	52.21	7.18	2.22	0.65	0.78	0.91
Preadipocyte - breast, donor2	11328-117E5	62.14	7.66	3.60	0.45	0.23	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	64.57	10.23	2.13	0.85	0.32	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	52.38	8.73	0.44	0.44	0.87	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	36.96	8.59	1.58	1.00	1.72	0.43	0.86
Preadipocyte - perirenal, donor1	11469-119C2	14.76	2.95	0.00	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	16.58	4.61	0.61	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.38	4.78	2.83	0.35	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	21.63	3.24	0.85	0.34	0.17	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	35.21	6.61	1.02	0.19	0.19	0.28	0.09
Preadipocyte - visceral, donor2	11357-117H7	33.59	3.68	1.84	0.46	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	19.23	4.28	2.61	0.10	0.21	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	64.72	5.43	2.87	0.60	0.45	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	17.47	2.98	0.54	0.14	0.00	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	45.93	4.23	1.16	0.55	0.86	0.18	0.55
Prostate Stromal Cells, donor1	11254-116F3	40.78	7.63	1.48	0.23	0.57	0.00	0.23
Prostate Stromal Cells, donor2	11332-117E9	45.00	9.50	1.97	0.54	0.18	0.18	0.54
Prostate Stromal Cells, donor3	11405-118E1	32.74	7.20	1.77	0.42	0.42	0.10	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	0.73	0.73	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	41.79	4.02	0.90	0.07	0.07	0.14	0.07
Renal Epithelial Cells, donor1	11517-119H5	9.64	3.55	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	1.42	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	41.29	4.76	1.27	0.00	0.00	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	0.68	0.68	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.98	2.43	1.08	0.13	0.00	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	26.20	2.66	0.89	1.33	0.89	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.14	1.98	0.22	0.22	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	18.81	3.13	1.25	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	0.83	0.55	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	21.47	5.10	0.81	0.27	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	19.40	2.11	0.42	0.42	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.23	1.93	0.19	0.00	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.26	4.15	1.04	0.26	0.26	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	25.30	7.96	0.57	0.28	0.28	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	1.03	1.03	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	42.91	3.76	1.25	0.00	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	89.67	16.44	3.21	1.20	1.34	0.67	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	85.77	8.04	0.89	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	235.56	21.46	3.85	4.95	0.55	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	135.73	13.92	0.58	2.90	1.74	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	61.50	14.30	2.60	0.91	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	51.54	8.74	2.28	1.69	0.00	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	63.24	12.94	3.01	0.11	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	78.89	14.26	4.59	0.37	0.50	0.99	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	56.52	10.14	4.20	1.05	0.47	0.23	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	74.89	12.71	3.70	1.16	0.69	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	53.39	8.21	3.42	0.68	0.27	1.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	63.23	9.83	2.42	0.91	0.30	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.31	10.75	2.87	0.36	0.00	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	43.32	7.03	2.15	1.29	0.14	1.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	48.51	7.40	2.90	0.97	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	52.66	9.51	3.32	0.44	0.44	1.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	43.21	5.93	1.72	2.68	0.19	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	47.70	9.22	2.33	0.93	0.93	0.75	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	85.31	10.90	2.07	0.19	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	39.15	6.10	1.99	1.86	0.13	0.66	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	52.56	8.86	1.46	0.88	0.49	0.49	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	55.95	14.32	3.06	1.91	0.19	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	39.73	8.12	1.07	0.96	0.32	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.85	7.85	2.52	2.52	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	53.83	10.25	1.88	0.34	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	39.38	8.75	0.36	1.28	0.00	1.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	49.67	7.97	2.70	1.10	0.25	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	51.58	11.28	2.01	0.54	0.67	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	54.72	12.03	2.59	1.18	0.00	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	54.37	10.71	2.98	0.40	0.79	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.45	12.63	4.91	0.47	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	46.65	10.37	2.28	0.62	0.83	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.96	8.41	1.33	0.00	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	46.79	10.44	2.51	0.42	0.00	0.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	50.87	9.56	2.56	1.21	0.81	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	34.74	8.51	2.90	0.51	0.51	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	55.72	9.45	2.31	1.35	0.58	0.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	51.24	11.52	4.81	1.55	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	34.98	6.45	2.19	1.78	0.14	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.83	12.31	3.61	0.49	0.66	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.76	6.14	2.05	1.70	0.00	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	48.09	11.24	2.81	0.30	1.18	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	49.58	6.66	0.80	0.53	0.80	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	58.76	10.09	2.77	1.94	0.41	0.55	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	51.91	6.90	3.57	0.71	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	68.93	10.28	1.21	1.61	1.61	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.03	8.29	2.07	0.57	0.09	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	102.71	13.97	5.94	0.70	1.75	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	74.95	9.07	2.72	1.51	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.58	8.08	2.33	0.73	0.37	0.73	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	219.20	31.88	9.46	1.31	1.31	0.73	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	120.47	13.39	3.65	0.61	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.64	9.34	2.41	0.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	103.59	13.35	4.98	1.13	0.23	0.45	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	147.97	17.37	3.59	0.60	2.40	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	117.13	20.43	3.54	0.47	0.24	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	106.72	13.45	3.84	0.85	1.07	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	132.22	12.62	3.61	4.81	1.20	1.80	1.20
Schwann Cells, donor1	11498-119F4	14.67	2.44	0.19	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	34.02	6.80	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	17.31	3.29	1.75	0.44	0.44	0.22	0.00
Sebocyte, donor1	11220-116B5	29.03	4.93	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	19.30	0.92	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	21.44	2.06	0.41	0.41	0.00	0.21	0.41
Sertoli Cells, donor1	11255-116F4	39.76	4.97	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	70.61	11.30	2.82	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	57.01	9.77	2.73	0.44	0.35	0.26	0.09
Skeletal Muscle Cells, donor2	11358-117H8	18.07	2.89	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	1.67	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	42.89	7.23	2.36	0.79	0.16	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	38.50	5.50	2.68	0.59	0.59	0.89	0.15
Skeletal Muscle Cells, donor6	11459-119B1	44.94	7.08	2.92	0.15	0.00	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	104.46	16.38	4.03	0.63	1.51	0.13	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	64.50	12.70	4.28	0.71	0.43	0.43	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	42.66	7.74	1.49	0.20	0.50	0.60	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	48.53	8.68	2.27	0.34	0.51	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	4.34	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	25.59	3.85	1.51	0.00	0.28	0.69	0.00
Skin - palm, donor1	10286-104F7	77.90	5.37	5.37	18.80	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.05	0.29	0.14	0.14	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	430.21	49.89	6.54	14.72	5.73	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.79	0.52	0.26	0.26	0.26	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	43.23	4.87	2.09	0.14	0.42	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	39.95	4.92	2.95	0.84	0.56	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	277.84	46.31	8.46	1.69	0.85	1.48	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	43.77	4.20	1.35	0.97	0.45	0.45	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.32	1.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	170.31	34.91	2.67	0.67	0.44	1.11	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	16.46	4.11	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.34	6.41	0.44	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.06	1.18	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.13	3.86	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	82.06	12.01	3.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.90	2.26	0.67	0.13	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	38.12	6.43	1.33	1.33	0.22	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	38.15	5.63	1.02	0.51	0.26	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	33.86	6.84	2.28	0.00	0.33	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	44.89	8.27	1.18	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	26.19	4.13	1.28	0.00	0.14	0.00	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	0.98	0.00	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	46.27	10.35	1.83	2.44	0.91	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	24.50	4.80	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.17	2.86	0.48	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	33.03	6.34	1.18	0.44	0.15	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	38.31	5.60	1.08	0.22	0.00	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.71	6.72	0.94	0.21	0.52	0.21	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.61	3.25	0.31	0.00	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	3.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.76	1.20	1.49	0.30	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.46	1.02	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	80.41	9.50	1.18	0.31	0.47	0.08	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	31.60	8.35	0.91	0.20	0.40	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	37.09	5.69	3.64	1.14	0.68	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	1.21	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	27.29	4.24	0.79	0.26	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	41.15	11.98	1.73	0.93	0.13	0.53	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.09	11.02	1.75	1.00	0.25	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.13	7.10	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.90	2.71	0.15	0.15	0.00	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	3.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	29.72	0.00	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.95	3.72	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	2.02	1.51	0.00	1.01	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.97	2.51	0.63	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	2.06	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.41	4.08	0.75	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.02	5.14	0.00	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.52	3.17	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.71	2.80	0.76	0.25	0.76	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.29	1.69	0.75	0.19	0.00	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	22.64	3.77	0.56	0.28	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	13.49	2.93	0.50	0.08	0.00	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.92	3.18	0.49	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.72	7.29	2.21	0.66	0.44	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	42.13	7.02	1.46	0.00	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	59.67	9.91	1.36	0.97	0.78	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	39.67	7.67	1.32	1.32	1.32	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	90.01	14.13	2.98	1.49	1.49	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	51.03	7.91	2.52	2.16	1.44	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.29	5.39	0.85	0.57	1.14	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.60	6.70	1.58	0.39	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	54.09	8.63	1.02	1.78	0.51	0.00	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	37.54	5.19	1.60	2.00	2.00	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	36.37	2.93	1.25	0.42	1.25	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	47.67	6.88	3.21	2.29	0.46	0.46	0.92
Synoviocyte, donor1	11291-117A4	36.36	3.37	1.85	0.00	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	33.36	7.38	2.51	1.17	0.50	0.17	0.34
Synoviocyte, donor3	11440-118H9	37.53	6.48	2.23	0.22	0.45	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	12.86	4.29	0.36	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	3.96	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.07	2.55	0.23	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	16.06	2.29	0.93	0.14	0.29	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	15.85	2.71	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	0.00	1.15	0.57	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	94.73	18.21	3.69	1.60	1.35	0.49	0.12
Urethra, donor2	10319-105A4	59.35	19.78	3.60	35.97	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	8.24	1.06	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	12.42	0.40	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.02	0.46	0.46	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	32.54	3.57	1.78	0.22	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	185.07	57.84	6.23	1.78	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	193.00	71.48	12.87	4.29	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	177.98	33.54	4.79	0.68	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	201.44	53.37	9.99	1.72	2.41	2.07	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	216.14	44.16	10.46	1.74	1.74	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	178.05	56.23	7.29	0.00	0.00	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	212.93	64.25	13.77	1.84	1.84	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	188.06	27.39	8.22	2.74	4.56	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	54.53	11.10	1.11	1.48	0.74	0.37	0.49
Wilms' tumor cell line:HFWT	10597-108E3	66.88	5.28	7.04	4.40	3.52	7.04	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	36.31	7.26	1.96	0.84	0.28	0.56	0.00
achilles tendon, donor2	10292-104G4	64.06	4.13	2.07	6.20	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	104.28	14.53	5.86	3.57	3.57	1.27	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	138.38	30.18	7.20	1.39	0.70	1.16	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	283.47	43.80	15.08	3.09	2.37	1.42	1.66
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	124.63	20.68	1.90	2.45	0.54	0.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	97.25	19.68	5.90	1.69	1.41	1.41	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	87.55	23.69	3.60	0.42	0.21	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	157.61	20.96	12.25	6.26	6.26	1.63	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	97.82	11.46	7.05	2.20	1.32	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	180.49	33.89	8.17	5.31	4.08	3.27	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	154.54	48.93	4.27	5.82	10.48	3.88	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	70.66	17.48	5.89	1.47	1.66	0.92	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	187.22	46.81	3.90	0.00	23.40	39.01	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	115.73	20.22	4.18	0.93	1.39	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	132.04	24.85	5.95	2.33	2.85	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	77.15	16.66	4.38	2.34	2.05	1.17	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	84.59	15.80	5.58	2.32	0.46	2.79	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	92.12	6.58	3.29	2.06	0.41	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	15.04	3.68	0.61	3.07	1.23	1.84	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	85.77	31.58	0.43	0.43	0.43	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.99	25.17	2.12	0.61	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	74.62	25.76	1.68	0.96	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	44.77	14.92	3.12	1.34	1.34	1.34	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	81.05	10.01	2.67	0.67	0.67	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	7.43	1.86	3.72	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	72.70	16.20	0.75	1.13	0.75	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	123.43	25.73	4.80	2.18	1.74	1.31	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	118.09	11.25	9.37	5.62	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	67.59	16.01	0.71	1.18	0.47	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	68.87	12.56	1.24	0.16	0.16	0.16	0.16
adipose, donor1	10184-103D4	235.74	32.25	19.35	9.97	2.93	1.76	4.10
adipose, donor2	10185-103D5	57.99	6.89	4.46	4.06	3.65	1.22	0.41
adipose, donor3	10186-103D6	74.33	13.89	6.53	3.27	2.72	0.54	0.82
adipose, donor4	10187-103D7	64.14	15.60	6.07	5.20	6.07	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	48.29	16.57	2.05	2.05	0.63	0.95	0.16
adrenal gland, adult, pool1	10081-102A9	90.94	7.28	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	134.07	30.82	4.67	1.87	1.47	0.67	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	77.89	14.29	6.07	1.43	3.57	2.14	0.71
amniotic membrane cells, donor1	12235-129G3	44.28	5.10	1.39	0.00	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	73.03	9.47	1.35	1.35	0.68	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	59.80	7.66	2.95	3.54	0.59	0.88	0.29
amygdala - adult, donor10196	10167-103B5	182.61	27.27	5.93	7.11	0.00	3.56	1.19
amygdala, adult, donor10252	10151-102I7	188.17	36.30	7.50	21.29	9.33	5.47	1.01
amygdala, newborn, donor10223	10360-105E9	87.15	13.88	4.84	6.78	2.90	1.61	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	165.40	33.23	8.15	1.66	1.27	0.89	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	81.41	15.66	7.06	2.65	3.09	2.21	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	133.61	29.73	11.02	8.35	9.35	7.68	1.34
aorta, adult, pool1	10052-101G7	125.92	17.65	0.98	1.18	0.98	0.59	0.20
appendix, adult	10189-103D9	221.62	41.14	8.15	5.05	1.16	6.60	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	114.87	24.08	6.19	1.38	2.41	1.72	0.34
artery, adult	10190-103E1	92.39	14.95	8.15	0.00	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	108.07	12.02	6.66	2.61	1.16	0.29	0.43
b cell line:RPMI1788	10427-106D4	142.16	35.69	5.20	1.93	0.59	0.74	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	82.40	10.27	2.50	1.11	0.83	0.00	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	90.80	17.37	1.89	0.50	0.79	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	81.51	14.90	4.02	1.34	1.67	0.67	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	137.57	38.03	7.27	3.36	2.80	2.80	1.12
bladder, adult, pool1	10011-101C2	78.87	14.56	1.74	0.54	0.43	0.76	0.22
blood, adult, pool1	10053-101G8	81.94	8.86	2.21	2.21	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.11	5.99	1.71	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	94.48	18.90	2.02	1.35	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	90.21	34.85	1.03	3.08	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	80.85	17.82	2.00	1.45	1.11	0.33	0.56
brain, fetal, pool1	10085-102B4	122.88	26.71	5.34	0.00	5.34	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	104.73	12.88	6.61	4.29	3.63	5.62	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	84.26	22.84	2.37	0.87	0.50	0.37	0.62
breast, adult, donor1	10080-102A8	65.66	5.68	0.63	2.53	1.26	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	43.07	21.60	1.52	0.76	1.65	0.51	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	95.24	20.72	6.18	3.40	2.78	5.88	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	291.92	89.79	18.88	4.83	1.38	2.53	5.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	33.65	9.68	4.12	2.42	1.94	2.18	0.00
carcinoid cell line:NCI-H1770	10703-109H1	110.02	20.69	14.58	5.64	6.58	5.64	1.88
carcinoid cell line:NCI-H727	10735-110B6	42.44	7.22	1.09	0.44	0.33	0.33	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	123.59	20.60	11.73	4.12	2.54	5.39	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	199.90	26.62	5.86	5.59	4.79	0.80	2.13
caudate nucleus - adult, donor10196	10177-103C6	232.57	40.30	5.76	29.93	5.76	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	191.59	39.15	5.69	10.88	5.19	1.51	0.17
caudate nucleus, adult, donor10258	10379-105H1	147.48	31.33	7.64	9.93	3.06	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	111.70	24.90	3.66	5.13	1.83	2.20	0.00
cerebellum - adult, donor10196	10173-103C2	463.21	157.32	2.91	20.39	5.83	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	533.14	147.32	5.98	13.66	3.84	3.42	2.14
cerebellum, adult, pool1	10083-102B2	111.76	33.46	3.79	4.48	1.38	0.34	1.38
cerebellum, newborn, donor10223	10357-105E6	237.46	57.29	7.47	11.62	1.66	1.66	0.00
cerebral meninges, adult	10188-103D8	57.99	8.07	8.32	7.31	10.34	4.79	0.00
cerebrospinal fluid, donor2	10294-104G6	38.74	3.65	0.73	6.58	5.12	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	272.04	97.34	7.62	1.73	1.58	1.87	2.44
cervical cancer cell line:ME-180	10553-107I4	150.64	35.30	6.96	1.82	2.32	1.49	0.66
cervix, adult, pool1	10013-101C4	117.06	29.71	3.99	1.05	1.78	0.84	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	143.80	22.43	7.38	1.25	1.25	0.98	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	96.94	13.55	3.98	1.12	0.62	0.25	0.75
choriocarcinoma cell line:SCH	10785-110H2	59.63	8.26	1.72	1.23	1.11	0.12	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	52.65	5.93	4.03	0.71	1.90	1.42	0.00
chorionic membrane cells, donor1	12238-129G6	37.32	4.56	1.42	0.28	0.57	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	40.27	3.28	1.39	0.70	0.40	0.20	0.00
chorionic membrane cells, donor3	12240-129G8	57.15	2.75	1.65	2.75	0.00	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	18.18	4.04	5.05	2.02	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	77.03	17.67	2.88	0.96	0.96	1.15	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	106.44	28.51	2.53	2.11	1.06	0.42	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	101.18	13.35	1.80	1.03	0.26	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	108.60	15.48	5.32	2.18	0.48	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	127.66	28.51	1.63	1.43	0.61	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	174.61	50.65	10.31	6.18	2.65	1.47	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	170.71	46.65	2.35	0.26	0.26	0.26	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	104.23	12.80	2.74	1.37	1.37	1.37	1.37
clear cell carcinoma cell line:TEN	10636-108I6	97.86	17.87	1.56	1.04	1.56	0.87	0.35
colon carcinoma cell line:CACO-2	10513-107D9	70.47	10.80	2.75	0.37	0.37	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	364.12	62.33	4.94	1.52	1.14	0.00	0.38
colon, adult, donor1	10082-102B1	114.24	30.94	4.76	1.19	4.76	0.00	1.19
colon, adult, pool1	10014-101C5	81.43	20.09	3.41	1.88	1.18	1.18	0.00
colon, fetal, donor1	10070-101I7	118.65	16.69	8.03	6.18	7.42	8.65	0.00
common myeloid progenitor CMP, donor1	12130-128D6	343.76	178.76	0.00	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	446.60	72.66	8.50	2.97	0.85	1.70	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	165.57	28.98	6.19	2.41	1.06	0.30	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	190.79	35.53	6.06	0.99	0.71	0.42	0.99
corpus callosum, adult, pool1	10042-101F6	125.60	34.16	1.88	1.00	0.33	0.55	0.33
cruciate ligament, donor2	10295-104G7	78.62	19.45	6.48	11.35	3.24	4.05	0.81
diaphragm, fetal, donor1	10069-101I6	97.11	15.25	5.62	1.61	1.61	4.82	0.00
diencephalon, adult	10193-103E4	62.88	11.28	4.08	1.68	2.16	3.12	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	384.60	63.60	11.25	5.97	5.28	1.61	5.28
ductal cell carcinoma cell line:KLM-1	10438-106E6	147.97	37.95	4.10	1.28	0.77	0.77	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	155.51	24.79	6.50	2.89	2.41	0.72	1.69
ductus deferens, adult	10196-103E7	135.55	35.38	7.97	6.48	1.50	3.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	152.66	36.01	7.20	5.76	2.88	5.76	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	229.52	41.93	14.71	8.09	2.94	2.94	1.47
dura mater, adult, donor1	10041-101F5	109.51	46.00	1.57	0.17	0.08	0.25	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	163.67	25.76	1.11	0.89	0.44	1.33	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	84.26	15.19	4.01	0.72	1.15	0.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	58.58	4.32	0.62	3.70	0.62	2.47	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	88.39	9.69	2.72	2.72	1.21	0.91	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	76.88	7.72	0.93	2.47	0.62	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	77.49	7.88	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	88.83	21.45	4.36	3.02	4.69	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	125.96	22.65	3.26	2.90	2.54	0.18	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	49.37	6.43	1.29	0.48	0.16	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	52.47	7.11	1.67	0.33	0.44	0.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	77.65	15.95	2.20	0.55	0.11	0.22	0.11
epididymis, adult	10197-103E8	118.26	38.30	5.44	2.30	0.84	1.88	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	79.83	15.26	3.37	2.66	1.77	1.42	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	50.33	10.62	1.97	1.18	0.79	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	208.76	39.97	5.77	1.70	1.70	0.92	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	299.89	56.79	4.13	2.76	1.57	0.98	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	181.04	39.77	4.71	1.46	1.68	1.01	1.34
esophagus, adult, pool1	10015-101C6	49.27	11.04	1.38	0.32	0.42	0.21	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	320.48	88.17	6.39	2.00	1.00	0.88	0.63
eye - muscle inferior rectus, donor1	10272-104E2	127.97	12.07	9.66	53.12	2.41	26.56	0.00
eye - muscle lateral, donor2	10298-104H1	90.48	6.31	6.31	18.94	2.10	4.21	0.00
eye - muscle medial, donor2	10299-104H2	49.11	4.46	8.93	14.88	7.44	7.44	0.00
eye - muscle superior, donor2	10297-104G9	79.11	10.32	3.44	18.34	4.59	6.88	0.00
eye - vitreous humor, donor1	10268-104D7	43.72	4.37	0.00	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	60.25	11.69	2.54	1.27	1.53	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	91.55	10.64	1.80	1.80	1.67	0.77	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.65	6.89	3.32	1.90	1.42	1.19	0.24
frontal lobe, adult, pool1	10040-101F4	138.39	38.66	3.19	0.75	0.47	0.19	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	96.38	30.02	5.40	6.00	4.20	2.10	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	46.63	9.24	1.65	0.09	0.18	0.37	0.00
gall bladder, adult	10198-103E9	91.02	18.59	2.41	1.21	1.93	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	354.86	75.16	16.64	4.29	5.37	4.29	2.68
gamma delta positive T cells, donor2	11938-126A3	245.76	38.84	12.70	0.75	3.36	1.12	2.99
gastric adenocarcinoma cell line:MKN1	10614-108G2	167.92	17.74	3.38	1.90	1.69	0.42	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	147.19	31.91	2.90	5.22	1.74	1.16	0.77
gastric cancer cell line:AZ521	10549-107H9	91.00	21.81	4.92	0.33	0.98	1.31	0.16
gastric cancer cell line:GSS	10560-108A2	157.42	41.19	4.58	0.92	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	189.16	11.65	4.34	2.28	1.83	0.46	0.46
giant cell carcinoma cell line:LU65	10487-107B1	72.40	22.26	3.21	0.69	1.38	0.23	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	204.48	90.41	2.94	1.54	0.42	0.14	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	45.39	10.48	2.99	1.50	0.00	2.24	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.42	11.19	2.32	0.84	0.74	1.27	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	36.23	11.24	2.39	1.69	1.97	1.40	0.00
glioblastoma cell line:T98G	10485-107A8	94.26	21.08	6.51	2.32	2.10	0.99	0.44
glioma cell line:GI-1	10413-106B8	101.04	15.52	1.76	0.29	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	121.73	18.95	5.10	14.58	7.29	4.37	0.00
globus pallidus, adult, donor10252	10161-103A8	230.91	32.46	6.10	20.26	8.30	2.93	0.98
globus pallidus, adult, donor10258	10367-105F7	80.78	15.06	8.22	8.22	9.58	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	65.55	9.59	2.13	2.66	3.20	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	181.09	110.12	0.00	2.45	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	65.60	4.80	2.56	1.28	1.28	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	73.46	5.05	6.89	0.46	4.13	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	72.70	5.03	5.49	2.29	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	83.09	1.93	3.22	1.93	1.93	1.29	0.00
hIPS, biol_rep1	14380-156B6	84.80	1.44	5.75	2.87	5.75	0.00	0.00
hIPS, biol_rep2	14381-156B7	68.59	3.43	8.23	2.06	1.37	1.37	0.00
hIPS, biol_rep3	14382-156B8	102.62	12.14	1.10	11.03	4.41	2.21	2.21
hairy cell leukemia cell line:Mo	10712-109I1	81.32	15.52	7.47	1.44	0.86	2.59	0.29
heart - mitral valve, adult	10205-103F7	101.35	22.12	4.19	2.69	1.79	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	103.81	19.35	3.40	5.23	0.78	2.61	0.52
heart - tricuspid valve, adult	10207-103F9	94.09	20.82	9.99	9.99	12.49	13.32	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	69.58	12.45	1.22	0.41	0.20	1.22	0.41
heart, adult, diseased, donor1	10051-101G6	106.03	11.92	3.41	1.70	2.98	0.00	0.00
heart, adult, pool1	10016-101C7	44.16	5.75	3.68	0.46	1.15	1.38	0.00
heart, fetal, pool1	10046-101G1	159.36	39.63	2.16	0.62	0.51	0.51	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	50.60	7.10	0.62	2.16	1.54	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	55.89	8.32	4.76	5.95	1.19	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	59.34	6.30	1.44	0.88	0.33	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	63.24	7.40	0.85	0.61	0.49	0.36	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	80.84	12.13	1.21	0.30	0.81	0.10	0.20
hepatoma cell line:Li-7	10484-107A7	157.48	17.13	7.45	2.22	1.56	0.89	1.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	79.70	10.95	3.22	1.51	1.31	0.70	0.90
hippocampus - adult, donor10196	10169-103B7	143.84	29.34	9.46	29.34	20.82	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	194.92	29.19	5.51	22.45	8.98	8.16	1.22
hippocampus, adult, donor10258	10374-105G5	129.47	13.44	5.98	9.96	4.48	1.49	0.50
hippocampus, newborn, donor10223	10363-105F3	87.06	14.45	2.11	2.11	5.29	2.11	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	178.83	10.99	5.49	1.83	3.66	2.44	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	85.02	4.91	5.11	1.57	1.96	1.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	89.88	5.33	6.86	3.55	2.54	1.78	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	110.52	19.17	7.33	5.07	2.82	0.56	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	170.94	12.91	3.36	2.58	1.55	2.07	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	133.62	17.84	4.93	3.80	3.80	1.90	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	164.95	22.77	2.92	2.63	1.46	1.17	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	146.28	27.36	6.25	3.66	0.86	0.86	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	128.88	27.11	4.17	3.75	3.34	1.25	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	94.24	16.81	3.55	1.66	0.24	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	116.20	19.45	4.66	1.93	0.96	0.32	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	82.14	22.22	3.37	0.67	1.35	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	87.79	7.98	5.01	2.19	1.10	1.56	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	109.07	7.37	2.95	0.98	0.49	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	138.77	6.98	4.36	3.49	0.00	1.75	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	165.71	18.71	7.83	5.73	1.72	1.53	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	146.08	17.88	5.67	3.92	0.44	3.49	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	193.91	20.49	9.00	6.50	4.00	2.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	103.05	16.20	3.39	1.51	1.13	1.13	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	115.95	18.64	2.27	0.45	0.45	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	95.85	17.23	3.45	5.33	4.07	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	93.57	13.39	4.57	1.80	1.31	0.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	82.74	12.48	2.90	1.16	1.74	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	91.17	12.26	5.38	1.79	0.60	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	95.51	9.05	9.24	1.85	1.85	0.74	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	86.73	7.42	5.14	2.00	2.00	2.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	151.08	11.43	8.57	4.90	5.72	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	182.38	17.25	3.87	1.41	1.76	2.11	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	108.64	9.19	10.77	0.63	0.32	1.58	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	118.63	9.68	9.38	4.54	3.93	1.21	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	108.60	18.62	3.10	2.07	1.03	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	135.49	22.58	4.65	3.32	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	91.07	13.34	5.90	2.57	1.80	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	119.39	13.04	5.37	0.77	0.51	0.77	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	110.55	11.36	2.27	1.51	3.03	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	85.36	12.77	4.03	5.04	1.68	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	97.09	8.21	6.52	1.21	1.93	1.21	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	114.53	10.25	12.03	1.78	2.67	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	112.20	8.29	11.71	4.88	5.37	2.44	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	153.73	14.06	7.33	1.53	0.92	2.44	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	956.45	104.10	22.77	19.52	0.00	0.00	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	207.17	29.45	9.60	4.30	5.30	1.32	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	142.84	23.53	5.47	2.74	1.09	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	124.49	20.99	5.43	4.34	1.45	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	122.06	24.56	4.98	3.56	2.85	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	108.60	21.48	3.58	1.19	1.19	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	121.34	24.92	4.60	0.54	0.81	0.68	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	73.81	12.12	5.39	3.50	3.23	1.35	0.27
immature langerhans cells, donor1	11904-125F5	68.29	7.75	0.97	0.73	0.48	0.00	0.24
immature langerhans cells, donor2	11905-125F6	108.52	31.69	1.58	0.79	0.79	0.00	1.58
insula, adult, pool1	10039-101F3	177.15	47.98	2.08	0.66	0.95	0.38	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	10.08	1.30	0.98	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	73.39	14.22	3.80	0.90	1.00	0.80	0.10
kidney, fetal, pool1	10045-101F9	177.97	43.43	1.77	0.92	0.35	0.57	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	141.31	22.16	4.26	1.70	1.14	0.71	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	208.05	16.87	7.47	2.21	1.52	0.97	2.21
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.84	9.17	1.65	2.02	1.47	2.75	0.00
left atrium, adult, donor1	10079-102A7	46.86	8.72	1.63	3.81	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	39.44	4.05	2.53	2.02	1.01	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	49.25	12.31	1.37	1.64	0.27	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	19.76	2.51	1.08	0.00	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	14.67	3.80	2.17	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	28.90	4.61	1.21	0.00	0.00	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	63.78	15.68	3.14	2.09	1.05	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	195.62	33.29	2.72	1.42	2.13	1.06	1.06
liposarcoma cell line:KMLS-1	10782-110G8	67.33	10.31	1.87	0.78	1.25	0.94	0.78
liposarcoma cell line:SW 872	10726-110A6	58.24	7.92	2.56	2.07	0.73	0.37	0.37
liver, adult, pool1	10018-101C9	32.74	7.78	1.13	0.65	0.49	0.16	0.16
liver, fetal, pool1	10086-102B5	38.57	10.35	0.94	1.88	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	79.18	15.31	5.54	18.67	5.40	3.79	0.00
locus coeruleus, adult, donor10252	10165-103B3	147.83	26.76	4.06	5.72	4.06	0.92	0.55
locus coeruleus, adult, donor10258	10375-105G6	70.53	10.72	4.51	4.80	3.67	2.26	1.41
locus coeruleus, newborn, donor10223	10362-105F2	152.26	26.08	2.94	10.94	5.89	2.94	0.42
lung adenocarcinoma cell line:A549	10499-107C4	62.00	10.66	4.15	1.11	0.97	0.97	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	15.17	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	97.54	10.68	2.50	0.92	0.66	0.79	0.53
lung, adult, pool1	10019-101D1	61.54	14.53	1.54	1.30	1.06	0.35	0.24
lung, fetal, donor1	10068-101I5	390.15	95.61	6.56	4.28	0.00	1.14	1.14
lung, right lower lobe, adult, donor1	10075-102A3	94.39	21.08	4.12	5.50	2.75	3.67	0.92
lymph node, adult, donor1	10077-102A5	88.52	8.99	1.89	0.95	1.89	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	92.71	15.56	4.16	1.97	2.85	2.41	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	115.01	26.86	2.11	0.60	0.45	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	242.11	32.28	4.25	0.85	1.70	3.40	0.00
mature adipocyte, donor1	12231-129F8	45.73	8.88	1.78	0.44	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	45.24	7.89	1.45	0.83	0.83	1.04	0.00
mature adipocyte, donor3	12233-129G1	50.02	10.90	1.42	0.71	0.95	0.00	0.00
mature adipocyte, donor4	12234-129G2	72.65	12.11	2.63	0.79	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	212.29	98.16	2.14	2.86	0.24	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	168.08	33.84	5.64	6.77	3.38	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	212.60	35.49	4.05	15.08	4.78	2.57	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	91.49	16.20	6.04	3.81	3.18	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	183.39	33.27	2.56	3.41	0.00	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	301.73	32.40	2.70	14.01	1.69	0.68	6.24
medial temporal gyrus, adult, donor10252	10156-103A3	235.57	32.47	6.15	42.02	11.67	5.94	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	84.76	9.63	5.78	15.41	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	430.61	43.06	57.41	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	92.96	16.87	4.67	2.87	1.79	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	116.17	26.61	6.49	5.84	3.89	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	170.28	34.52	4.80	5.88	1.70	1.55	0.77
medulla oblongata, adult, pool1	10038-101F2	84.81	25.55	1.63	0.73	0.33	0.33	0.16
medulla oblongata, newborn, donor10223	10361-105F1	86.10	19.44	5.90	6.25	1.39	2.08	0.00
medulloblastoma cell line:D283 Med	10838-111E1	723.80	98.09	12.18	6.42	3.54	2.44	5.31
medulloblastoma cell line:ONS-76	10759-110E3	27.76	5.14	0.61	0.61	0.24	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	87.69	13.51	1.87	0.43	1.01	0.14	0.86
melanoma cell line:G-361	10465-106H6	122.43	21.99	4.07	1.63	0.81	1.36	1.90
meningioma cell line:HKBMM	10691-109F7	87.38	9.05	4.34	1.09	0.54	0.36	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	131.29	31.72	10.57	4.41	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	79.32	19.70	5.96	1.04	1.30	1.81	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.36	7.52	1.84	0.31	0.15	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	56.17	5.27	3.27	0.00	0.36	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	62.12	10.35	2.48	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.65	6.74	2.25	0.28	0.14	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.99	9.24	3.27	1.16	0.19	0.77	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	68.71	12.49	3.47	1.39	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	61.62	11.67	2.06	0.17	0.17	0.34	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	59.81	7.94	1.84	0.92	0.12	0.58	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.43	7.16	2.39	0.13	0.13	0.40	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.60	6.48	1.62	0.14	0.14	0.14	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	45.81	6.12	1.00	0.00	0.14	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	94.52	14.49	4.28	2.31	0.99	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	42.48	6.78	1.52	0.42	0.00	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	38.05	7.33	2.79	0.35	0.70	1.40	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	37.36	4.49	1.63	0.61	0.00	0.82	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	53.20	10.42	3.24	2.52	1.08	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.52	5.38	1.45	0.10	0.00	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	54.72	10.26	2.74	1.82	1.37	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	43.21	12.59	0.84	0.00	0.84	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	45.88	8.52	1.64	0.15	0.00	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	49.02	7.35	2.28	0.44	0.35	0.88	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	72.90	9.94	4.42	1.10	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	94.72	12.30	4.01	2.00	1.72	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	25.68	5.47	4.21	0.42	1.26	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.53	8.22	2.28	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	64.46	6.14	3.58	1.02	0.51	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	51.04	8.64	3.93	0.79	1.05	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	56.38	9.24	5.55	1.54	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	67.78	12.47	2.82	0.71	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.86	10.15	3.05	0.00	0.34	0.00	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	51.09	10.61	2.75	0.39	0.79	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	52.36	10.19	1.85	1.39	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	64.03	9.23	3.46	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	53.32	9.59	2.90	0.89	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	61.05	11.78	3.61	0.48	0.24	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	87.27	9.53	1.47	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	48.33	7.38	1.68	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	54.04	11.05	0.41	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	59.28	6.87	3.01	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	2.73	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	87.80	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	53.26	6.50	1.62	1.30	0.97	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	68.38	7.27	5.82	0.00	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	60.77	10.13	2.13	1.07	1.60	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	41.71	4.09	0.82	1.64	0.82	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	43.54	10.50	2.33	1.55	0.00	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	8.39	6.30	4.20	0.00	2.10	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	50.67	6.95	3.97	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	4.77	4.77	4.77	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	53.37	7.71	2.37	1.19	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	51.18	10.97	1.22	1.22	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	53.20	6.97	2.53	0.00	0.63	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	59.67	6.55	2.07	1.38	2.07	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	58.03	4.30	4.30	4.30	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	0.00	3.99	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	20.66	10.33	6.89	0.00	3.44	13.78
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	55.42	2.85	4.07	1.22	1.63	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	61.17	6.36	1.59	0.00	1.59	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	50.11	4.13	4.13	1.77	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	55.80	5.30	2.49	0.62	0.94	0.94	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	64.16	6.68	5.35	2.67	1.34	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	53.22	11.83	3.55	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	71.90	5.14	5.14	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	46.81	6.20	4.82	2.07	0.69	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	49.98	9.90	1.98	0.99	0.99	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	4.49	4.49	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.35	8.27	3.18	1.27	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.81	2.82	5.64	1.21	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	8.72	2.18	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	27.88	3.80	1.27	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	57.65	10.92	2.43	0.00	1.21	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	22.59	9.04	4.52	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	54.36	7.41	5.77	1.65	4.12	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	37.90	6.94	3.77	0.60	0.00	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	39.26	8.44	4.22	0.00	0.97	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	44.82	12.22	3.06	2.04	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	37.14	8.51	0.77	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.25	10.87	1.89	1.89	1.18	1.18	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	60.00	18.07	2.32	1.16	0.70	1.62	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	0.00	8.55	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.24	4.11	1.13	0.82	0.41	0.21	2.67
mesothelioma cell line:Mero-25	10850-111F4	62.87	5.22	2.27	0.68	0.23	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	51.58	14.91	2.20	0.98	0.49	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	50.49	7.75	2.21	0.22	0.66	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	85.15	9.46	5.78	1.31	0.53	0.26	1.58
mesothelioma cell line:Mero-83	10854-111F8	78.30	7.49	3.06	0.68	0.85	0.17	1.02
mesothelioma cell line:Mero-84	10855-111F9	41.20	6.07	0.76	0.51	0.76	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	44.51	5.80	1.45	0.83	1.04	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	50.85	7.29	3.98	0.83	0.17	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	45.43	3.80	1.81	0.18	0.18	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	78.24	15.03	3.59	0.68	0.17	0.85	0.34
mesothelioma cell line:NCI-H28	10845-111E8	92.12	14.00	3.82	1.78	1.27	1.27	0.76
mesothelioma cell line:No36	10857-111G2	53.50	11.09	1.96	0.00	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	53.65	8.13	1.35	0.00	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	94.62	23.80	1.34	0.77	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	77.79	13.80	1.10	0.85	0.37	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	112.18	18.85	3.77	1.44	0.90	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	150.18	12.73	9.79	5.55	1.96	3.59	3.26
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.49	2.12	2.12	0.85	0.85	0.85	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	93.29	11.75	2.30	3.23	1.38	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	119.88	15.98	4.57	1.52	2.28	1.33	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	243.19	39.36	6.10	2.77	2.40	0.74	2.03
myeloma cell line:PCM6	10474-106I6	205.38	33.80	4.55	1.98	1.58	0.99	2.57
myxofibrosarcoma cell line:MFH-ino	10600-108E6	75.59	5.58	1.52	3.04	1.01	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.81	4.90	0.98	0.98	0.39	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.75	5.91	1.67	0.45	0.11	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	51.04	6.03	1.84	0.29	0.07	0.15	0.22
nasal epithelial cells, donor2	12227-129F4	30.36	7.18	1.10	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	254.45	52.91	10.12	6.21	4.83	1.61	0.23
neuroblastoma cell line:NB-1	10539-107G8	117.68	43.22	10.10	1.50	1.68	1.12	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	330.46	33.11	9.28	5.69	4.01	2.11	1.90
neuroblastoma cell line:NH-12	10555-107I6	189.89	25.72	10.06	5.78	3.73	0.75	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	222.52	54.09	9.25	11.15	4.03	3.56	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	170.10	31.04	3.48	4.12	4.75	0.63	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	162.01	26.16	6.84	6.44	6.24	2.82	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	71.21	7.63	1.91	4.45	2.54	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	62.02	11.45	2.13	1.33	1.60	1.86	0.00
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	53.12	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	37.88	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	669.89	66.80	10.49	3.04	2.54	0.85	5.24
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.82	6.40	1.60	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	67.65	12.18	2.24	0.96	0.32	0.32	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	74.89	7.62	3.68	0.79	0.00	0.53	1.31
nucleus accumbens, adult, pool1	10037-101F1	145.86	44.62	2.44	1.03	0.09	0.37	0.47
occipital cortex - adult, donor10196	10172-103C1	263.73	28.85	4.12	2.06	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	266.48	40.79	12.88	33.81	17.18	10.20	1.88
occipital cortex, newborn, donor10223	10355-105E4	96.08	15.65	2.18	1.82	0.36	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	105.48	13.64	5.51	9.71	4.20	2.36	0.26
occipital lobe, fetal, donor1	10073-102A1	258.75	48.92	9.44	21.46	6.01	3.00	1.29
occipital pole, adult, pool1	10036-101E9	95.71	29.57	1.34	0.47	0.16	0.39	0.16
olfactory region, adult	10195-103E6	116.54	19.49	3.25	10.89	3.06	3.25	0.38
optic nerve, donor1	10277-104E7	76.04	22.01	6.00	16.01	12.01	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.65	10.48	2.39	0.80	0.11	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	49.18	7.83	2.75	0.82	0.55	0.41	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	120.73	8.47	3.39	1.52	1.19	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	69.42	9.13	1.04	0.00	0.81	0.23	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	56.15	7.35	2.06	0.59	0.00	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	77.55	13.08	1.87	0.93	0.93	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	99.67	25.45	3.18	0.64	1.70	0.85	0.00
ovary, adult, pool1	10020-101D2	50.14	14.33	1.48	0.17	0.17	0.26	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.82	3.12	0.73	0.92	0.92	0.73	0.18
pancreas, adult, donor1	10049-101G4	151.44	38.57	1.88	1.88	1.88	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	96.44	15.65	7.27	2.52	2.52	3.63	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	245.48	25.89	5.62	2.38	1.87	0.51	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	119.55	23.35	1.82	0.17	0.66	0.83	0.33
paracentral gyrus, adult, pool1	10035-101E8	115.59	32.86	2.38	0.55	0.55	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	122.58	18.35	5.14	9.54	2.20	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	161.76	28.21	10.35	16.93	1.88	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	212.92	40.76	5.42	27.65	6.27	3.99	0.29
parietal lobe, adult, pool1	10034-101E7	118.70	37.01	1.41	0.62	0.44	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	327.80	75.65	17.46	24.25	7.76	3.88	2.91
parietal lobe, newborn, donor10223	10356-105E5	99.82	18.69	3.36	6.73	2.99	1.12	0.37
parotid gland, adult	10199-103F1	64.13	14.80	4.93	0.00	1.23	1.23	0.00
penis, adult	10200-103F2	102.05	33.84	8.06	3.22	1.07	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	53.55	5.02	0.93	0.37	0.56	0.19	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	43.85	7.72	2.19	1.02	1.31	1.02	0.29
pineal gland - adult, donor10196	10179-103C8	221.24	33.54	8.39	43.86	6.45	2.58	1.29
pineal gland, adult, donor10252	10160-103A7	551.35	91.20	5.92	11.84	3.55	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	171.19	33.23	5.64	5.64	1.88	3.14	1.88
pituitary gland - adult, donor10196	10180-103C9	176.05	38.45	4.05	5.06	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	268.93	83.91	1.56	1.56	0.52	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	86.83	27.24	1.70	5.11	0.85	0.85	0.85
placenta, adult, pool1	10021-101D3	49.45	6.56	2.15	0.43	0.54	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	219.83	29.66	5.56	2.65	2.38	0.40	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	100.39	20.39	3.58	1.87	0.93	1.09	0.47
pons, adult, pool1	10033-101E6	80.47	24.62	1.38	0.60	0.26	0.26	0.26
postcentral gyrus, adult, pool1	10032-101E5	143.93	30.60	2.96	0.61	0.70	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	16.73	4.18	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	23.47	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	36.42	6.70	1.17	0.58	0.15	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	96.20	27.95	4.90	2.54	3.09	2.72	0.91
prostate, adult, pool1	10022-101D4	62.31	19.05	1.45	0.63	0.45	0.91	0.18
putamen, adult, donor10196	10176-103C5	192.16	42.49	4.49	9.44	3.30	0.94	0.00
putamen, adult, donor10252	10152-102I8	127.45	23.53	21.57	7.84	5.88	5.88	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	93.98	8.74	6.56	1.09	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	100.51	25.13	5.07	5.07	3.87	0.00	0.97
putamen, newborn, donor10223	10365-105F5	208.41	32.24	4.50	7.50	3.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	108.23	27.93	2.91	3.78	1.16	1.75	0.00
rectum, fetal, donor1	10067-101I4	243.42	31.99	12.52	19.47	12.52	9.74	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	75.47	15.05	1.70	0.00	0.00	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	37.69	7.87	0.83	0.83	2.07	0.41	0.00
retina, adult, pool1	10030-101E3	145.52	47.71	1.79	0.30	0.70	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	114.57	29.10	6.75	3.90	2.34	2.60	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	82.87	9.71	3.20	3.44	3.32	1.84	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	52.87	10.12	3.37	2.25	0.84	1.97	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	23.49	6.82	0.76	0.76	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	62.31	12.95	1.29	1.46	0.00	0.32	0.65
salivary acinar cells, donor2	11772-123I8	90.74	18.04	1.65	1.10	0.55	0.28	0.83
salivary acinar cells, donor3	11773-123I9	52.96	7.94	1.32	3.97	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	171.01	54.91	5.15	0.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	82.20	27.57	0.76	0.67	0.67	0.17	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.94	24.80	1.06	0.59	0.94	0.47	0.71
seminal vesicle, adult	10201-103F3	132.80	35.45	13.23	5.82	2.65	2.12	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	266.25	52.96	6.56	3.64	2.19	1.46	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	43.53	7.05	1.51	1.01	0.00	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	46.16	11.04	3.01	2.01	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	136.74	11.42	6.98	1.48	1.88	1.34	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	113.18	27.19	4.53	0.88	0.33	0.55	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	112.38	29.93	2.84	1.03	0.90	1.42	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	80.15	6.38	1.42	7.80	1.42	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	47.62	7.20	2.76	1.08	1.08	0.84	0.00
skeletal muscle, fetal, donor1	10066-101I3	74.37	9.05	0.00	4.02	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	40.71	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	190.00	34.09	3.16	9.47	5.68	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	82.38	34.69	6.34	2.00	1.67	1.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	230.73	32.78	4.41	7.56	2.52	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	233.22	68.62	10.41	5.01	2.70	2.70	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	144.88	43.68	3.46	1.98	1.48	0.66	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	342.29	40.69	9.81	6.11	5.15	3.06	2.73
small cell lung carcinoma cell line:WA-hT	10562-108A4	154.29	31.60	3.27	2.18	1.74	1.31	0.22
small intestine, adult, pool1	10024-101D6	74.41	21.74	2.51	1.55	1.43	1.55	0.48
small intestine, fetal, donor1	10064-101I1	79.61	17.44	2.70	2.95	2.70	2.21	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	189.77	27.18	8.21	3.08	1.54	1.54	1.54
smooth muscle, adult, pool1	10048-101G3	116.82	20.68	1.29	2.33	1.81	1.55	0.52
somatostatinoma cell line:QGP-1	10781-110G7	81.75	11.52	2.14	2.14	0.80	2.68	0.00
spinal cord - adult, donor10196	10181-103D1	135.81	16.75	1.38	8.95	1.15	1.15	1.38
spinal cord, adult, donor10252	10159-103A6	196.74	37.06	3.94	8.28	3.55	1.18	0.39
spinal cord, adult, donor10258	10369-105F9	128.67	17.99	6.23	9.69	4.15	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	122.58	25.61	5.49	7.93	6.10	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	168.99	23.42	5.05	3.67	0.92	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	56.16	8.81	1.34	2.09	0.60	1.34	0.15
spleen, adult, pool1	10025-101D7	83.26	18.72	3.30	1.65	0.88	0.55	0.22
spleen, fetal, pool1	10044-101F8	228.67	46.72	1.19	1.03	0.08	0.24	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	137.88	46.06	3.93	1.04	0.52	0.10	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	66.08	9.87	3.23	2.85	1.90	2.66	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	66.05	10.13	1.05	1.75	0.70	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	139.95	8.99	3.13	1.95	0.39	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	71.25	32.19	6.08	2.36	1.80	0.68	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	105.48	19.06	0.85	0.42	0.85	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	152.73	18.62	3.38	4.65	0.85	2.96	0.85
stomach, fetal, donor1	10062-101H8	144.18	26.70	8.54	4.27	3.20	4.27	0.00
submaxillary gland, adult	10202-103F4	176.60	54.69	10.25	4.56	1.71	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	162.82	705.56	379.92	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	170.73	23.47	6.02	3.74	1.45	1.66	1.04
substantia nigra, adult, donor10258	10371-105G2	95.17	18.62	3.62	6.21	4.14	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	102.45	18.37	4.95	10.60	7.07	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	136.18	48.60	10.09	5.50	3.21	2.29	0.92
temporal lobe, adult, pool1	10031-101E4	129.02	29.50	2.37	0.68	0.76	0.34	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	235.05	49.86	6.41	14.96	14.25	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	181.97	33.40	13.19	6.59	4.83	3.08	0.00
tenocyte, donor1	11763-123H8	60.39	4.19	3.49	1.40	0.70	0.70	0.70
tenocyte, donor2	11765-123I1	53.79	7.63	4.20	0.76	0.38	0.38	0.38
tenocyte, donor3	11768-123I4	44.85	7.78	2.22	1.11	1.85	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	126.79	20.40	5.61	2.21	4.93	2.89	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	95.73	9.09	3.85	3.70	1.08	0.92	0.77
teratocarcinoma cell line:PA-1	10807-111A6	73.77	6.51	3.25	3.72	1.39	1.55	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	58.40	9.65	2.79	1.65	2.41	0.63	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	178.12	31.01	2.27	1.13	1.89	1.89	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	182.57	36.75	3.71	2.40	1.31	2.40	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	163.50	35.50	4.56	0.98	1.95	0.98	2.28
testis, adult, pool1	10026-101D8	52.18	13.96	1.29	0.32	0.43	0.32	0.21
testis, adult, pool2	10096-102C6	81.20	20.75	1.80	3.16	1.35	0.45	0.45
thalamus - adult, donor10196	10168-103B6	138.00	29.81	2.21	14.35	6.62	6.62	1.10
thalamus, adult, donor10252	10154-103A1	215.05	33.76	3.59	7.35	3.13	3.59	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	104.69	10.78	7.70	4.62	6.16	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	51.55	9.88	4.12	11.86	4.61	1.98	0.49
thalamus, newborn, donor10223	10366-105F6	85.72	10.93	5.18	11.51	0.58	2.30	0.58
throat, adult	10209-103G2	158.79	30.46	4.24	2.50	2.00	0.50	0.00
throat, fetal, donor1	10061-101H7	178.25	26.51	9.45	7.92	8.53	3.35	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	206.08	34.18	9.54	5.56	2.98	1.79	1.19
thymus, adult, pool1	10027-101D9	158.37	37.38	1.79	0.30	0.70	0.10	0.10
thymus, fetal, pool1	10043-101F7	332.29	69.10	2.81	1.66	0.73	0.31	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	92.41	10.90	2.93	1.06	0.53	0.93	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	111.61	22.07	3.63	1.96	1.40	1.12	0.84
thyroid, adult, pool1	10028-101E1	76.05	20.16	2.33	1.12	0.65	0.47	0.47
thyroid, fetal, donor1	10060-101H6	124.19	23.73	6.59	10.81	6.86	3.16	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	110.87	27.72	12.32	6.16	9.24	15.40	0.00
tongue, adult	10203-103F5	106.75	17.91	2.56	0.23	1.16	0.70	0.47
tongue, fetal, donor1	10059-101H5	76.45	9.85	2.76	1.97	1.18	1.97	0.00
tonsil, adult, pool1	10047-101G2	190.03	57.30	2.80	1.00	0.80	0.70	0.40
trachea, adult, pool1	10029-101E2	60.20	15.79	1.31	0.33	0.41	0.16	0.00
trachea, fetal, donor1	10058-101H4	139.64	25.77	6.16	5.39	4.62	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	41.10	11.69	3.19	0.71	0.71	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	132.32	17.02	1.42	0.91	0.71	0.51	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	75.84	18.18	5.01	1.41	1.10	1.25	0.16
tridermal teratoma cell line:HGRT	10694-109G1	20.93	1.90	0.00	3.81	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	67.13	13.04	2.03	0.93	1.95	0.68	0.68
umbilical cord, fetal, donor1	10057-101H3	77.20	6.26	6.26	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	183.77	56.48	4.27	0.85	0.17	0.51	0.51
uterus, fetal, donor1	10055-101H1	122.35	23.55	4.61	8.19	5.63	2.05	0.00
vagina, adult	10204-103F6	91.11	25.20	2.58	2.58	0.00	0.65	0.00
vein, adult	10191-103E2	120.56	23.45	4.16	2.85	0.66	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	103.34	16.29	2.94	1.34	1.60	1.07	0.27